Baker Bros. Advisors’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Hold |
4,916,095
| – | – | 0.22% | 35 |
|
|
2025
Q1 | $22.8M | Hold |
4,916,095
| – | – | 0.25% | 32 |
|
|
2024
Q4 | $34.1M | Hold |
4,916,095
| – | – | 0.36% | 32 |
|
|
2024
Q3 | $26.1M | Hold |
4,916,095
| – | – | 0.27% | 37 |
|
|
2024
Q2 | $18.4M | Hold |
4,916,095
| – | – | 0.24% | 40 |
|
|
2024
Q1 | $34.7M | Hold |
4,916,095
| – | – | 0.43% | 33 |
|
|
2023
Q4 | $27.8M | Hold |
4,916,095
| – | – | 0.32% | 35 |
|
|
2023
Q3 | $23.5M | Buy |
4,916,095
+1,892,144
| +63% | +$9.06M | 0.14% | 35 |
|
|
2023
Q2 | $20.7M | Buy |
3,023,951
+2,648,856
| +706% | +$18.1M | 0.12% | 42 |
|
|
2023
Q1 | $2.92M | Buy |
+375,095
| New | +$2.92M | 0.02% | 83 |
|